Call us!


Courteous professionals

ready to

answer your call!


What is "molly"?


“Ecstasy” and "Molly" are slang terms for MDMA, short for 3,4-methylenedioxymethamphetamine, a name that’s nearly as long as the all-night parties where MDMA is often used. That's why MDMA has been called a “club drug.” It has effects similar to those of other stimulants, and it often makes the person feel like everyone is his or her friend, even when that’s not the case.

MDMA is man-made—it doesn't come from a plant like marijuana or tobacco do. Other chemicals or substances—such as caffeine, dextromethorphan (found in some cough syrups), amphetamines, PCP, or cocaine—are sometimes added to, or substituted for, MDMA in Ecstasy or Molly tablets. Makers of MDMA can add anything they want to the drug, so its purity is always in question.

SLANG TERMS - There are a lot of slang words for MDMA. “Ecstasy” and "Molly" are two of the most common. You might also hear “E,” “XTC,” “X,” “Adam,” “hug,” “beans,” “clarity,” “lover's speed,” and “love drug."


MDMA (3,4-methylenedioxymethamphetamine), commonly referred to as ecstasy or molly, is a drug that is sold either as a pressed pill taken orally, or as a powder that is snorted or swallowed. MDMA’s effects resemble those of both stimulants and psychedelics. A typical dose of 100 to 125 mg lasts four to six hours.

  • People who use MDMA describe themselves as feeling open, accepting, unafraid and connected to people around them. Typically used in social settings, especially among the rave and dance club cultures, MDMA’s effects are stimulated by visuals, sounds, smells and touch. Some people experience nausea at the outset, but after about forty-five minutes, most people report feelings of relaxation and clarity. MDMA causes dilation of the pupils and, often, sensitivity to light. People using MDMA experience heightened sensations and want to intensify these feelings by dancing, talking and touching.

  • Most of MDMA’s potential harms derive from the setting of its use. Although few adverse effects have been reported, hyperthermia – a dangerously high increase in body temperature – is the most common problem related to ecstasy. Hyperthermic reactions result from physical exertion (such as dancing) in an overheated environment without replenishing fluids, which is why users take breaks and consume fluids like water or Gatorade. Overdoses are extremely rare. 

  • Because MDMA is illegal – and, therefore, unregulated – it is impossible know what a “dose” contains. In fact, many drugs sold as “ecstasy” or “molly” are not MDMA. Besides MDMA, ecstasy pills may contain varying levels of MDA (methylene-dioxyamphetamine), other stimulants such as caffeine, or anesthetics such as Ketamine or dextromethorphan (DXM) – which can significantly amplify potential harms. Testing kits are available to detect if pills contain MDMA or another drug, but cannot determine potency or purity.

  • Research evaluating MDMA’s therapeutic and medical applications has shown promising results. MDMA-assisted psychotherapy combines traditional psychotherapy with the administration of MDMA. Because of MDMA’s unique effect of diminishing fear and enhancing interpersonal trust, it is an ideal adjunct medicine to psychotherapy, and it has been administered to over 500 human subjects in clinical trials without a single serious adverse event. A seminal study published in 2010 found that PTSD patients who received MDMA-assisted psychotherapy reported overwhelming reductions in the severity of their symptoms – reductions which were sustained, on average, for more than three years. Such findings have been replicated by other studies, and additional research is underway in the U.S., Canada, Israel, U.K. and Australia.

  • MDMA was initially popularized by psychotherapists and other mental health practitioners in the late 1970s and early 1980s. After MDMA was placed in Schedule I in 1985, a lawsuit challenging this designation won a favorable ruling from the DEA Administrative Law Judge, who concluded that MDMA had "currently accepted medical use" and "acceptable safety" – yet it remains in Schedule I today. In 2002, the RAVE Act (“Reducing Americans’ Vulnerability to Ecstasy”) inc


1 Panel Methylenedioxymethamphetamine - MDMA - Ecstasy Drug Test Dip

Single Panel MDMA - Ecstasy Drug Test Dip Strip


The MDMA One Step Methylenedioxymethamphetamine Test Strip is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of Methylenedioxymethamphetamine in urine.

The One Step Drug Screen Test Card yields a positive result when the Methylenedioxymethamphetamine in urine exceeds 500 ng/mL.

#DIP-MDMA - Ecstasy Drug Test Dip (dip strip)


This Molly Drug Test Panel is an forensic, all inclusive, point of use  screening test for the rapid detection of Methamphetamines (including Ecstasy*), Amphetamines, in human urine at or above the system concentrations levels established as standard minimums by the National Institute on Drug Abuse (NIDA), the World Health Organization (WHO) and SAMHSA as shown in the chart below. Note system cut-off concentrations are expressed in nanograms per milliliter solution.


Urine based screening tests for drugs of abuse range from simple immunoassay tests to complex analytical procedures. The speed and sensitivity of lateral flow based immunoassays identical to that employed in our Multi-Drug 5 Panel Drug Test have made them the most widely accepted method for screening urine for drugs of abuse. our Multi-Drug Screen Panel Test is based on the principle of the highly specific immunochemical reactions of antigens and antibodies which are used for the analysis of specific compounds in human urine.  This Multi-Drug Screen Test is a rapid, visual, competitive panel immunoassay that can be used for the simultaneous, qualitative detection of the five (5) targeted drugs and their metabolites listed above. For a description of these drugs of abuse along with other useful background information please refer to the Drug Test FAQ page.  This Five Panel Multi-Drug Test is intended as an initial forensic screen for the presence of drug or drug metabolites at the time the test is performed. Because the test requires visual interpretation, it is recommended that a person other than the test subject interpret test results.



1. Read the enclosed instruction manual completely.
2. Do not open the sealed test pouch until just prior to sample testing.
3. Collect a fresh urine sample in a clean container preferably glass.
4. Check the expiration date and remove the test device from the sealed pouch. Do not use the test past its expiration date. Remove the test cap exposing the 10 absorbent wicks. Do not touch the wicks or otherwise contaminate them.
5. Dip the wicks only into the urine sample for approximately 20-30 seconds or until visible sample migration up the wicks and across
the tests panels is observed
6. Dip only the wicks. Do not allow the sample to come in contact with any other part of the test device or its plastic housing.
7. Read result within 3 to 8 minutes after the addition of samples. Do not read result after 8 minutes. If the drug test is left standing for longer than 8 minutes, the intensity of the colored lines may change or for technical reasons, a faint line may appear that should not be interpreted.
8. Photocopy both sides of the test card for a permanent record of test results.


Negative: Colored lines adjacent to each target drug name and in the control (C) regions will appear. The color intensity of the line for the target drug may be weaker or stronger than that of the control line however any line, no matter how faint should be interpreted as a negative result. Do not attempt to correlate the intensity or color of the test lines between the targeted drug panels. Also because development times vary for each target drug, results should not fully interpreted until 6-8 minutes have elapsed. Some drug panels, however, will develop test lines within 3 minutes or less producing negative results. A very faint line on the test region may indicate that the target drug in the sample is near the cutoff level for the test. While these results should be considered negative, confirmation of the sample by more analytical testing methods may be desired.

Positive: Colored lines appear in the control regions (C) but do not develop in the test region. The absence of any line in any target drug test region indicates a positive result for that drug or drug metabolite. The example shown is a positive test for THC and Opiates and negative test for all other drugs. Note that test lines are not of equal intensity or color. Because of the various sensitivity cutoff level for each specific drug this result is normal.
No line appears in the control region. Under no circumstances should a positive sample be identified until the control line (C) forms in the control test area. If the control line (C) does not form, the test result is inconclusive and the assay should be repeated with a new test device.

Note: our Molly Drug test panel is used to obtain visual qualitative result and is not intended as a quantitative assay.. This assay provides only a preliminary analytical test result as to the presence of the target drug and drug metabolites at the established minimum standards above. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography! mass spectrometry (GC/MS) has been established as the preferred confirmatory method by the Substance Abuse Mental Health Services Administration (SAMHSA). Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated. If confirmation of positive drug test is required, we suggest Laboratory Confirmation of positive drug test results.


Call us for more information
UA Test
UA Drug Test | Buy Drug Tests | Types of Drug Tests | Drug Testing Information | Drug Information | Contact Us
© 2014 Transmetron, Inc., All Rights Reserved